Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-11-20
1980-06-03
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424274, 424316, 424319, A61K 3124, A61K 31195, A61K 31205
Patent
active
042062322
ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
REFERENCES:
patent: 3462535 (1969-08-01), Loev et al.
patent: 3551419 (1970-12-01), DaRe et al.
patent: 3852338 (1974-12-01), Kaiser et al.
patent: 3896166 (1975-07-01), Kaiser et al.
patent: 4153725 (1979-05-01), Ondetti et al.
Berse et al., J. Org. Chem., vol. 27, 1962, pp. 3489-3495.
Vasilevskii et al., Zh. Org. Khimii, vol. 2, 1970, pp. 244-249.
Engel et al., PSEBM, vol. 143, 1973, pp. 483-487.
Cushman David W.
Ondetti Miguel A.
Davis Stephen B.
E. R. Squibb & Sons Inc.
Fagelson Anna P.
Levinson Lawrence S.
Smith Merle J.
LandOfFree
Relieving hypertension with carboxyalkylacylamino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Relieving hypertension with carboxyalkylacylamino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relieving hypertension with carboxyalkylacylamino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-716095